Six game-changing technologies targeted at disease areas ranging from treatment of autoimmunity, to cancer, glaucoma to receive funding and Bayer mentoring.
Generating Superior ‘Killers’ for Adoptive Cell Therapy in Cancer, Lydia Lynch, PhD, Brigham and Women’s Hospital
Novel Strategies to Enhance Tfr Treatment of Autoimmunity, Peter Sage, PhD, Brigham and Women’s Hospital
Long-Lasting mRNA Therapy for Genetic Disorders, Jinjun Shi, PhD, Brigham and Women’s Hospital
AAV-Based Gene Replacement Therapy Improves Targeting and Clinical Outcomes in a Childhood CNS Disorder, Yulia Grishchuk, PhD, Massachusetts General Hospital
Towards a Permanent Genetic Cure for Spinal Muscular Atrophy, Benjamin Kleinstiver, PhD, Massachusetts General Hospital
Differentiation of Retinal Neurons for Cell Replacement in Glaucoma, Petr Baranov, MD, PhD, Massachusetts Eye and Ear
Most Recent Posts:
The Medically Engineered Solutions in Healthcare (MESH) Incubator: A case study of innovation “push”
In an opinion piece for STAT, Marc Succi, MD, Clinician-in-Residence at Mass General Brigham Innovation, addresses the…
2022 World Medical Innovation Forum | Day 3 Recap
The final day of the World Medical Innovation Forum began with a discussion on the fast-moving landscape…
2022 World Medical Innovation Forum | Day 2 Recap
Day 2 of World Medical Innovation Forum kicked off with a fireside chat with FDA commissioner Robert…
